Ç¥Àû ´Ü¹éÁú ºÐÇØ ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Çâ, »ê¾÷ ºÐ¼® º¸°í¼­ : À¯Çüº°, Ä¡·á ºÐ¾ßº°, Åõ¿© °æ·Îº°, Áö¿ªº° - ½ÃÀå ¿¹Ãø(2025-2034³â)
Targeted Protein Degradation Market Size, Share, Trends, Industry Analysis Report: By Type, Therapeutic Area, Route of Administration, and Region - Market Forecast, 2025-2034
»óǰÄÚµå : 1605916
¸®¼­Ä¡»ç : Polaris Market Research
¹ßÇàÀÏ : 2024³â 11¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 116 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,250 £Ü 6,149,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,250 £Ü 7,596,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ 20¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,250 £Ü 9,043,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

Polaris Market ResearchÀÇ ÃֽŠÁ¶»ç¿¡ µû¸£¸é, ¼¼°è Ç¥Àû ´Ü¹éÁú ºÐÇØ ½ÃÀå ±Ô¸ð´Â 2034³â±îÁö 35¾ï 4,791¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ Á¶»ç º¸°í¼­´Â ÇöÀç ½ÃÀå ¿ªÇп¡ ´ëÇÑ ÀÚ¼¼ÇÑ ÀλçÀÌÆ®¿Í ÇâÈÄ ½ÃÀå ¼ºÀå¿¡ ´ëÇÑ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

Ç¥Àû ´Ü¹éÁú ºÐÇØ(TPD) ½ÃÀåÀº Á¤¹ÐÀÇ·áÀÇ ¹ßÀü°ú »ý¸í°øÇп¡ ´ëÇÑ ÅõÀÚ Áõ°¡¿¡ ÈûÀÔ¾î °ý¸ñÇÒ ¸¸ÇÑ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù. ÁÖ¿ä ¿øµ¿·ÂÀº Áö±Ý±îÁö 'Ä¡·áÇÒ ¼ö ¾ø¾ú´ø' ´Ü¹éÁúÀ» Ç¥ÀûÀ¸·Î »ï´Â TPDÀÇ ÀáÀç·ÂÀ¸·Î, ¾Ï ¹× ½Å°æ ÅðÇ༺ Áúȯ°ú °°Àº º¹ÀâÇÑ Áúº´¿¡ ´ëÇÑ »õ·Î¿î Ä¡·á¹ýÀ» Á¦½ÃÇÒ ¼ö ÀÖ´Ù´Â Á¡ÀÔ´Ï´Ù.

Á¦¾à»çµéÀÌ ÇÐ°è ¹× ÇÏÀÌÅ×Å© ±â¾÷µé°ú Çù·ÂÇÏ¿© »õ·Î¿î ºÐÇØÁ¦¸¦ °³¹ßÇÔ¿¡ µû¶ó ÀÌ ½ÃÀå °³Ã´ ±âȸ´Â ¿¹Ãø ±â°£ µ¿¾È Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ »õ·Î¿î Æ®·»µå¿Í ÀúºÐÀÚ Ä¡·áÁ¦¿¡ ´ëÇÑ °ü½É Áõ°¡µµ ½ÃÀå ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. Àü¹ÝÀûÀ¸·Î ¿¬±¸ Ȱµ¿°ú ÀÓ»ó½ÃÇèÀÌ Áõ°¡ÇÔ¿¡ µû¶ó TPD ½ÃÀåÀº ºü¸£°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Ç¥Àû ´Ü¹éÁú ºÐÇØ ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

À¯Çüº°·Î´Â ´Ü¹éÁú ºÐÇØ Ç¥Àû Ű¸Þ¶ó ºÐÀÚ(PROTACs) ºÐ¾ß°¡ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖÀ¸¸ç, ±¤¹üÀ§ÇÑ ´Ü¹éÁúÀ» ºÐÇØÇÒ ¼ö ÀÖ¾î ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. µ¥±Û·Î´Ï¹Ìµå´Â ÀúºÐÀÚ Ä¡·áÁ¦ÀÇ ¹ßÀü¿¡ ÈûÀÔ¾î ºü¸¥ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù.

Ä¡·á ºÐ¾ßº°·Î º¸¸é ¾Ï Ä¡·á°¡ Ç¥Àû ´Ü¹éÁú ºÐÇØ¿¡ Å©°Ô ÀÇÁ¸Çϰí ÀÖ¾î ¾Ï Áúȯ ºÐ¾ß°¡ °¡Àå Å« ºñÁßÀ» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ½Å°æÁúȯ ºÐ¾ß´Â ¾ËÃ÷ÇÏÀ̸Ӻ´ µî ½Å°æÅðÇ༺ Áúȯ¿¡ ´ëÇÑ ¿¬±¸°¡ Áõ°¡ÇÔ¿¡ µû¶ó ±Þ°ÝÇÑ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù.

Åõ¿© °æ·Îº°·Î´Â Á¤¸Æ Åõ¿©°¡ ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖ½À´Ï´Ù. Á¤¸Æ Åõ¿©´Â ƯÈ÷ Á÷Á¢ÀûÀ̰í ÅëÁ¦µÈ Àü´ÞÀÌ ÇÊ¿äÇÑ Ä¡·á¿¡ »ç¿ëµË´Ï´Ù.

ºÏ¹Ì´Â °­·ÂÇÑ R&D Ȱµ¿°ú ÀǾàǰ¿¡ ´ëÇÑ ÅõÀÚ·Î TPD ½ÃÀåÀ» ¼±µµÇϰí ÀÖ½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº ÀÇ·áºñ ÁöÃâ Áõ°¡, »ý¸í°øÇÐ ºÐ¾ßÀÇ ¼ºÀå, Çõ½ÅÀûÀÎ Ä¡·á¹ý¿¡ ´ëÇÑ °ü½É Áõ°¡·Î ÀÎÇØ °¡Àå ºü¸£°Ô ¼ºÀåÇÏ´Â Áö¿ªÀÔ´Ï´Ù.

ÀÌ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷À¸·Î´Â ¾Æ¸£ºñ³ª½º(Arvinas), Ä«À̸޶ó Å×¶óǻƽ½º(Kymera Therapeutics), ´©¸¯½º Å×¶óǻƽ½º(Nurix Therapeutics) µîÀÌ ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼Ò°³

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Á¶»ç ¹æ¹ý

Á¦4Àå ¼¼°èÀÇ Ç¥Àû ´Ü¹éÁú ºÐÇØ ½ÃÀå ÀλçÀÌÆ®

Á¦5Àå ¼¼°èÀÇ Ç¥Àû ´Ü¹éÁú ºÐÇØ ½ÃÀå : À¯Çüº°

Á¦6Àå ¼¼°èÀÇ Ç¥Àû ´Ü¹éÁú ºÐÇØ ½ÃÀå : Ä¡·á ºÐ¾ßº°

Á¦7Àå ¼¼°èÀÇ Ç¥Àû ´Ü¹éÁú ºÐÇØ ½ÃÀå : Åõ¿© °æ·Îº°

Á¦8Àå ¼¼°èÀÇ Ç¥Àû ´Ü¹éÁú ºÐÇØ ½ÃÀå : Áö¿ªº°

Á¦9Àå °æÀï ±¸µµ

Á¦10Àå ±â¾÷ °³¿ä

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global targeted protein degradation market size is expected to reach USD 3547.91 million by 2034, according to a new study by Polaris Market Research. The report "Targeted Protein Degradation Market Size, Share, Trends, Industry Analysis Report: By Type, Therapeutic Area (Inflammatory Disorders, Neurological Disorders, Oncological Disorders, Respiratory Disorders, and Others), Route of Administration, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The targeted protein degradation (TPD) market is experiencing significant growth, driven by advances in precision medicine and increased investments in biotechnology. A key driver is the potential of TPD to target previously "undruggable" proteins, opening new therapeutic avenues for complex diseases such as cancer and neurodegenerative disorders.

Opportunities in this market are expected to rise during the forecast period as pharmaceutical companies collaborate with academic institutions and tech firms to develop novel degraders. The emerging trend toward personalized medicine and the growing focus on small-molecule therapeutics also fuel market demand. Overall, with increasing research activities and clinical trials, the TPD market is poised for rapid expansion.

Targeted Protein Degradation Market Report Highlights:

Based on type, the proteolysis-targeting chimeric molecules (PROTACs) segment dominates the market, being widely adopted due to their ability to degrade a broad range of proteins. Degronimids are expected to witness rapid growth, driven by advancements in small-molecule therapeutics.

In terms of therapeutic area, the oncological disorders segment holds the largest share, as cancer treatments heavily rely on targeted protein degradation. The neurological disorders segment is projected to grow rapidly, with increasing research on neurodegenerative diseases such as Alzheimer's.

By route of administration, the intravenous segment dominates the market; the IV route is especially used for therapies requiring direct and controlled delivery.

North America leads the TPD market, owing to strong R&D activities and pharmaceutical investments. Asia Pacific is the fastest-growing region, driven by rising healthcare expenditure, growing biotechnology sectors, and an increasing focus on innovative therapies.

Some of the key players in the market are Arvinas, Kymera Therapeutics, and Nurix Therapeutics.

Polaris Market Research has segmented the targeted protein degradation market report on the basis of type, therapeutic area, route of administration, and region:

By Type Outlook (Revenue - USD Million, 2020-2034)

By Therapeutic Area Outlook (Revenue - USD Million, 2020-2034)

By Route of Administration Outlook (Revenue - USD Million, 2020-2034)

By Regional Outlook (Revenue - USD Million, 2020-2034)

Table of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Global Targeted Protein Degradation Market Insights

5. Global Targeted Protein Degradation Market, by Type

6. Global Targeted Protein Degradation Market, by Therapeutic Area

7. Global Targeted Protein Degradation Market, by Route of Administration

8. Global Targeted Protein Degradation Market, by Geography

9. Competitive Landscape

10. Company Profiles

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â